Sfoglia per Autore

opzioni
Mostrati risultati da 1 a 15 di 15
Titolo Data di pubblicazione Autore(i) File
The limit for chronic myeloid leukemia relapse after allogeneic hematopoietic stem cell transplant moves ever forward: when can you safely talk about healing? 1-gen-2013 Perrone, Salvatore; Barberi, Walter; Foa, Roberto; Iori, ANNA PAOLA; Breccia, Massimo; Girmenia, Corrado; Valle, Veronica; Natalino, Fiammetta; Scalzulli, Emilia; Torelli, Giovanni Fernando; Puzzolo, MARIA CRISTINA
Strongyloides stercoralis infection in allogeneic stem cell transplant: a case report and review of the literature. 1-gen-2014 Iori, ANNA PAOLA; Ferretti, Antonietta; Gentile, Giuseppe; Gabrielli, Simona; Perrone, Salvatore; Barberi, Walter; Torelli, Giovanni Fernando; Natalino, F; Scalzulli, Emilia; Totino, V; Foa, Roberto; Cancrini, G; Girmenia, C.
Incidence and outcome of infections after unrelated cord blood transplantation in patients with hematological malignancies: a long-term single center experience 1-gen-2015 Scalzulli, E.; Barberi, W.; Girmenia, C.; Gentile, G.; Torelli, G. F.; Ballaro, D.; Testi, A. M.; Moleti, M. L.; Lombardi, L.; Campanelli, M.; Foa, R.; Iori, A. P.
Changes in estimated glomerular filtration rate in chronic myeloid leukemia patients treated front line with available TKIs and correlation with cardiovascular events 1-gen-2018 Molica, Matteo; Scalzulli, Emilia; Colafigli, Gioia; Alunni Fegatelli, Danilo; Massaro, Fulvio; Latagliata, Roberto; Foà, Robin; Breccia, Massimo
Identification of predictive factors for overall survival at baseline and during azacitidine treatment in high-risk myelodysplastic syndrome patients treated in the clinical practice 1-gen-2019 Scalzulli, Emilia; Molica, Matteo; Alunni Fegatelli, Danilo; Colafigli, Gioia; Rizzo, Lorenzo; Mancini, Marco; Efficace, Fabio; Latagliata, Roberto; Foà, Robin; Breccia, Massimo
Ten-year outcome of chronic-phase chronic myeloid leukemia patients treated with imatinib in real life 1-gen-2019 Molica, Matteo; Colafigli, Gioia; Scalzulli, Emilia; Alunni Fegatelli, Danilo; Chiatamone Ranieri, Sofia; Rizzo, Lorenzo; Diverio, Daniela; Efficace, Fabio; Latagliata, Roberto; Foà, Robin; Breccia, Massimo
Hemorrhagic Complications in Patients Treated With Azacitidine and Direct Oral Anticoagulants 1-gen-2020 Serrao, Alessandra; Scalzulli, Emilia; Breccia, Massimo; Foà, Robin; Chistolini, Antonio
A Multicenter Real-Life Study On Anticoagulant Treatment With Direct Oral Anticoagulants In Patients With Ph Negative Myeloproliferative Neoplasms 1-gen-2020 Serrao, Alessandra; Breccia, Massimo; Napolitano, Mariasanta; Fiori, Luciano; Santoro, Marco; Scalzulli, Emilia; Santopietro, Michelina; Santoro, Cristina; Raso, Simona; Chistolini, Antonio
Digital droplet PCR as a predictive tool for successful discontinuation outcome in chronic myeloid leukemia. is it time to introduce it in the clinical practice? 1-gen-2020 Colafigli, G.; Scalzulli, E.; Di Prima, A.; Pepe, S.; Loglisci, M. G.; Diverio, D.; Martelli, M.; Foa, R.; Breccia, M.
Concomitant Administration of Direct Oral Anticoagulants in Chronic Phase Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors 1-gen-2020 Serrao, Alessandra; Scalzulli, Emilia; Fiori, Luciano; Di Prima, Alessio; Breccia, Massimo; Chistolini, Antonio
Erythropoietin treatment in chronic phase chronic myeloid leukemia patients treated with frontline imatinib who developed late anemia 1-gen-2020 Cesini, L.; Frieri, C.; Barate, C.; Sora, F.; Bonifacio, M.; Cerrano, M.; Cagnetta, A.; Elena, C.; Aprile, L.; Sgherza, N.; Trawinska, M.; Gozzini, A.; Capodanno, I.; Crugnola, M.; Carmosino, I.; Scalzulli, E.; Ricci, F.; Bocchia, M.; Bergamaschi, M.; Aguzzi, C.; Sica, S.; Galimberti, S.; Breccia, M.; Luciano, L.; Latagliata, R.
Real-life comparison of nilotinib versus dasatinib as second-line therapy in chronic phase chronic myeloid leukemia patients 1-gen-2021 Scalzulli, Emilia; Caocci, Giovanni; Efficace, Fabio; Rizzo, Lorenzo; Colafigli, Gioia; Di Prima, Alessio; Pepe, Sara; Alunni Fegatelli, Danilo; Carmosino, Ida; Diverio, Daniela; Latagliata, Roberto; La Nasa, Giorgio; Martelli, Maurizio; Foà, Robin; Breccia, Massimo
Therapeutic strategies in low and high-risk MDS: What does the future have to offer? 1-gen-2021 Scalzulli, E.; Pepe, S.; Colafigli, G.; Breccia, M.
Long-term follow-up of late chronic phase chronic myeloid leukemia patients treated with imatinib after interferon failure: a single center experience 1-gen-2021 Pepe, S.; Scalzulli, E.; Colafigli, G.; Di Prima, A.; Mancini, M.; Diverio, D.; Latagliata, R.; Martelli, M.; Foa, R.; Breccia, M.
Emerging concepts for assessing and predicting treatment-free remission in chronic myeloid leukemia patients 1-gen-2022 Breccia, M.; Scalzulli, E.; Pepe, S.; Colafigli, G.; Bisegna, M. L.; Capriata, M.; Martelli, M.
Mostrati risultati da 1 a 15 di 15
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile